Drug facts
Compounded tirzepatide with B12, B6 or glycine
Quick answer
No approved tirzepatide product contains B12, B6 or glycine — the label lists every ingredient, and none of them is a vitamin or an amino acid. An add-in is something a compounding pharmacy puts in, and every trial of tirzepatide was run on the product without one. Under FDA’s reading of the law, adding B12 does not by itself make a compounded vial a different drug.
What is in the approved product1
Zepbound’s label ends the question of what the approved drug contains, because section 11 lists it. A single-dose pen or vial holds the dose of tirzepatide and sodium chloride, sodium phosphate dibasic heptahydrate and water for injection, with acid or base added only to adjust the pH. The multi-dose vial and KwikPen add the preservatives a vial you draw from several times needs — benzyl alcohol, glycerin and phenol.
That is the complete list. There is no cyanocobalamin, no pyridoxine, no glycine and no niacinamide in it, at any strength, in any presentation. So when a seller sells “tirzepatide with B12”, the B12 is not part of tirzepatide as approved; it is the pharmacy’s addition.
What the add-ins are3
- B12
- Cyanocobalamin, a vitamin. It is also an approved drug in its own right, sold as an injection — which matters for the next section.
- B6
- Pyridoxine, also a vitamin with its own approved injection. That label’s indication is pyridoxine deficiency — from poor diet, certain drugs, or inborn errors of metabolism.
- Glycine
- An amino acid. It has no role in any tirzepatide label.
On the label — Mounjaro / Zepbound
Every efficacy and safety figure for tirzepatide — the weight changes in SURMOUNT-1, the side-effect rates — was measured on a product with none of these in it.
In a compounded vial
A vial with an add-in is not what any trial of tirzepatide tested. Whatever the add-in is meant to do, the evidence for tirzepatide does not say it does it, and does not say it is harmless in combination either. It is simply not the thing that was studied.
Why compounders add them4
The label gives no clinical reason for an add-in. The law gives a practical one. Since FDA declared the tirzepatide shortage over, a state-licensed pharmacy compounding under section 503A may not regularly make drugs that are “essentially copies of a commercially available drug product.” The statute carves out one exception, and its wording is the whole story:
the term “essentially a copy of a commercially available drug product” does not include a drug product in which there is a change, made for an identified individual patient, which produces for that patient a significant difference, as determined by the prescribing practitioner, between the compounded drug and the comparable commercially available drug product.
A vial that differs from Zepbound — an extra ingredient, an unusual strength — can look like that kind of change. FDA addressed this directly.5 Its April 2026 statement says it may consider a product that combines the GLP-1 with “another API, such as vitamin B12 (cyanocobalamin), to be essentially a copy” when it is given the same way as the approved products and “the amounts of semaglutide and vitamin B12 in the compounded drug product are within 10% of the strengths of the respective commercially available drug products.” FDA’s example names semaglutide; the test it applies is written for any compounded drug, tirzepatide included.
So an add-in is not a loophole by itself. What the law cares about is whether a prescriber determined that you needed the difference. The rest of the legal position — including the four-prescription policy most large sellers rely on — is on is compounded tirzepatide still legal?
Why your vial may look different2
Zepbound’s label describes the approved solution as “clear, colorless to slightly yellow.”1 Cyanocobalamin, by its own label, “appears as dark, red crystals or as an amorphous or crystalline, red powder.” A compounded vial with B12 in it may therefore not look like the approved product at all, and that alone is not a sign that something is wrong.
What the color should be is a question only the pharmacy that made your vial can answer, because it depends on what went into it and how much. Ask before your first dose rather than guessing. And if a vial arrives warm, the storage rules apply whatever its color — see how long compounded tirzepatide lasts out of the fridge.
Sellers in this index selling an add-in version6
At least 8 sellers in this index sell a tirzepatide product whose own page names an add-in — 6 of them B12. We did not record ingredients for every seller, so this is a floor, not a count of the whole market.
- Bayan Health — tirzepatide with B6
- Brello Health — tirzepatide with B6
- CeliaRx — tirzepatide with B12
- EllieMD — tirzepatide with B12
- June Health — tirzepatide with B12 and Glycine
- Lumora — tirzepatide with B12
- RxPepsDirect — tirzepatide with B12
- Stealth Health — tirzepatide with B12 and Glycine
Each seller’s page shows what it actually bills per calendar month, and the product page the price was read from.
What to ask the pharmacy
- How much of each ingredient is in one milliliter? You need the tirzepatide concentration to measure a dose at all — see units, milligrams and milliliters — and the add-in’s amount is part of what makes the preparation what it is.
- Why is the add-in in my prescription? If the answer is a documented reason that applies to you, that is the exception the law describes. If it is a standard recipe every patient gets, it is not.
- What is the beyond-use date, and what color should it be? Both belong to the pharmacy, and both should be on or with your label.
If you want to know what compounded tirzepatide is in the first place — and what a pharmacy is and is not permitted to make — start with what compounded tirzepatide is.
Questions
- Why is B12 added to compounded tirzepatide?
- Not for any reason in a tirzepatide label — no approved tirzepatide product contains B12. Where an add-in matters is legal: a pharmacy may not regularly compound essentially a copy of an approved drug, and an added ingredient can look like a difference. FDA has said a GLP-1 combined with B12 may still be treated as essentially a copy unless a prescriber documents a significant difference for an identified patient.
- Is compounded tirzepatide with B12 better than without?
- There is no evidence either way. Every trial of tirzepatide tested the approved product, which contains no B12, B6 or glycine, so no figure you have seen quoted was measured on a vial with an add-in.
- Why is my compounded tirzepatide red or pink?
- If it contains B12, that may be why: cyanocobalamin is itself a red compound, while the approved product is described as clear and colorless to slightly yellow. Only the pharmacy that made your vial can say what color it should be, so ask it before using a vial that looks unexpected.
- Does adding B6 or glycine make it a different drug?
- Not by itself. The approved label contains neither, and under section 503A what matters is whether a prescriber determined that an identified patient needed the change, not whether the vial contains something extra.
Sources
- FDA prescribing information for ZEPBOUND (tirzepatide), section 11, revision 8/2026 DailyMed
- Cyanocobalamin Injection, USP prescribing information (Fresenius Kabi), Description DailyMed
- Pyridoxine Hydrochloride Injection, USP prescribing information (Fresenius Kabi), Indications and Usage DailyMed
- 21 U.S.C. 353a(b)(1)(D) and (b)(2), section 503A of the Federal Food, Drug, and Cosmetic Act U.S. Code
- FDA, 'FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize', content current as of 04/01/2026 FDA
- This site's price index — the product page each price was read from Read it